NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Establishing Clinical Utility for a New Diagnostic Test for Patients With Shortness of Breath
Establishing Clinical Utility for a New Diagnostic Test for Patients With Shortness of Breath
CompletedNA
Sponsor: Qure Healthcare, LLC
Conditions: Dyspnea, Unexplained Chronic Dyspnea
Interventions: Education Materials and Janssen Test
Countries: United States
This study will collect high-quality data on how practicing specialist physicians, specifically cardiologists and pulmonologists, across the U.S. currently manage patients with unexplained chronic dyspnea and and how the results of Janssen Pharmaceuticals' test change clinical decision making. To do so, this study leverages simulated patient cases called Clinical Performance and Value vignettes (CPVs) in a proven methodology to rapidly measure physician care decisions.
Eligibility overview
Sex: ALL
Healthy volunteers: Yes
Study type: INTERVENTIONAL
Eligibility criteria
Inclusion Criteria: 1. Board-certified cardiologist or pulmonologist for at least two years 2. Averaging at least 20 hours per week of clinical and patient care duties over the last six months 3. Routinely evaluate patients for unexplained or chronic dyspnea in their practice 4. Practicing in the U.S. 5. English speaking 6. Access to the internet 7. Informed, signed and voluntarily consented to be in the study Exclusion Criteria: 1. Non-English speaking 2. Practicing in an academic setting 3. Unable to access the internet 4. Not practicing in the U.S. 5. Not averaging at least 20 hours per week of clinical or patient care duties over the last six months 6. Do not voluntarily consent to be in the study
Locations (1)
- San Francisco, California, United States